{"id":"bone-marrow-mesenchymal-stem-cells","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Infection risk"},{"rate":null,"effect":"Immune response"}]},"_chembl":{"chemblId":"CHEMBL5315110","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Mesenchymal stem cells (MSCs) are multipotent cells harvested from bone marrow that can differentiate into various cell types (osteocytes, chondrocytes, adipocytes) and secrete immunomodulatory and anti-inflammatory cytokines. Upon transplantation, they home to damaged tissues, replace lost cells, and create a regenerative microenvironment. This mechanism supports tissue repair and functional recovery in degenerative or traumatic conditions.","oneSentence":"Bone marrow mesenchymal stem cells differentiate and engraft into damaged tissues to promote regeneration, reduce inflammation, and restore tissue function.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:44:03.624Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Tissue regeneration and repair (specific indications in phase 3 trials not fully specified in available data)"}]},"trialDetails":[{"nctId":"NCT07498218","phase":"PHASE1","title":"Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue","status":"NOT_YET_RECRUITING","sponsor":"Ayu, Inc.","startDate":"2026-03-02","conditions":"Diabetic Foot Ulcer (DFU), Granulation of Chronic Diabetic Wounds","enrollment":24},{"nctId":"NCT04476901","phase":"PHASE2","title":"Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy","status":"RECRUITING","sponsor":"Joshua M Hare","startDate":"2021-05-07","conditions":"Non-ischemic Dilated Cardiomyopathy","enrollment":136},{"nctId":"NCT02032004","phase":"PHASE3","title":"Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2014-03-03","conditions":"Chronic Heart Failure","enrollment":565},{"nctId":"NCT07471074","phase":"NA","title":"Phenotypic and Functional Study of Bone Marrow Mesenchymal Stem Cells in Waldenström Macroglobulinemia","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2026-02-10","conditions":"Waldenström Macroglobuloinemia","enrollment":50},{"nctId":"NCT04749667","phase":"PHASE1, PHASE2","title":"Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Haukeland University Hospital","startDate":"2021-08-09","conditions":"Multiple Sclerosis, Progressive Multiple Sclerosis","enrollment":18},{"nctId":"NCT06915233","phase":"PHASE3","title":"A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle","status":"RECRUITING","sponsor":"Vericel Corporation","startDate":"2026-03","conditions":"Chondral Defect, Articular Cartilage Defect","enrollment":309},{"nctId":"NCT03896568","phase":"PHASE1","title":"MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2019-02-12","conditions":"IDH1 wt Allele, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma","enrollment":36},{"nctId":"NCT07434115","phase":"EARLY_PHASE1","title":"Orthobiological Therapies in Musculoskeletal Disorders","status":"NOT_YET_RECRUITING","sponsor":"PROREGEN","startDate":"2026-01-30","conditions":"Musculoskeletal Diseases or Conditions","enrollment":300},{"nctId":"NCT07431008","phase":"","title":"Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction","status":"RECRUITING","sponsor":"Pharmicell Co., Ltd.","startDate":"2024-12-26","conditions":"Erectile Dysfunction","enrollment":32},{"nctId":"NCT05354141","phase":"PHASE3","title":"Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)","status":"RECRUITING","sponsor":"Direct Biologics, LLC","startDate":"2022-07-01","conditions":"Acute Respiratory Distress Syndrome, ARDS","enrollment":970},{"nctId":"NCT06918808","phase":"PHASE2","title":"DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease","status":"RECRUITING","sponsor":"Direct Biologics, LLC","startDate":"2025-05-19","conditions":"Perianal Fistula Due to Crohn's Disease","enrollment":36},{"nctId":"NCT04594850","phase":"PHASE2","title":"Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2020-10-19","conditions":"Erectile Dysfunction","enrollment":54},{"nctId":"NCT01652209","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2013-09-01","conditions":"Acute Myocardial Infarction","enrollment":90},{"nctId":"NCT05820711","phase":"PHASE1","title":"Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2023-07-17","conditions":"Head and Neck Cancer, Xerostomia","enrollment":23},{"nctId":"NCT05553132","phase":"PHASE1","title":"A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daniel B. F. Saris","startDate":"2023-08-08","conditions":"Cartilage Defect","enrollment":15},{"nctId":"NCT05095532","phase":"PHASE1","title":"Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2021-12-01","conditions":"Chronic Pancreatitis, Mesenchymal Stem Cells","enrollment":42},{"nctId":"NCT06919081","phase":"PHASE2","title":"Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease","status":"RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-08-01","conditions":"Persistent Corneal Epithelial Defect, Corneal Epithelial Disorders","enrollment":24},{"nctId":"NCT06752577","phase":"","title":"Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-12-22","conditions":"Chronic Kidney Diseases, Kidney Transplant","enrollment":75},{"nctId":"NCT02677350","phase":"PHASE1","title":"AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE)","status":"WITHDRAWN","sponsor":"Joshua M Hare","startDate":"2019-12-01","conditions":"Crohn's Disease, Fistulizing Crohn's Disease, Stem Cells","enrollment":""},{"nctId":"NCT07143812","phase":"PHASE1","title":"A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma","status":"RECRUITING","sponsor":"CHA University","startDate":"2025-10-23","conditions":"Glioblastoma (GBM), Newly Diagnosed Glioblastoma Multiforme","enrollment":10},{"nctId":"NCT06001853","phase":"PHASE2","title":"Allogeneic BM-MSC's in Patients With Lumbar Facet Arthropathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-11-03","conditions":"Facet-Mediated Low Back Pain","enrollment":40},{"nctId":"NCT05491681","phase":"PHASE1","title":"AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial","status":"WITHDRAWN","sponsor":"BioCardia, Inc.","startDate":"2026-01-04","conditions":"ARDS, Human","enrollment":""},{"nctId":"NCT02962661","phase":"PHASE1","title":"Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-07-18","conditions":"Cardiomyopathy, Heart Failure, Hematopoietic and Lymphoid Cell Neoplasm","enrollment":72},{"nctId":"NCT04650568","phase":"NA","title":"Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction","status":"ENROLLING_BY_INVITATION","sponsor":"Rush University Medical Center","startDate":"2017-11-03","conditions":"Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Rupture","enrollment":100},{"nctId":"NCT07066228","phase":"NA","title":"Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Long Tubular Bone Defects","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Xinxiang Medical College","startDate":"2025-08-07","conditions":"Defective Composite Restorations, Bone Cysts, Bone Defect","enrollment":30},{"nctId":"NCT06910384","phase":"PHASE2","title":"A Study of STRO4 in Patients Amyotrophic Lateral Sclerosis (ALS)","status":"TERMINATED","sponsor":"New England Cell Therapeutics, Inc.","startDate":"2025-08-12","conditions":"Amyotrophic Lateral Sclerosis","enrollment":1},{"nctId":"NCT05705024","phase":"PHASE2","title":"Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells","status":"RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2023-09-29","conditions":"Corneal Ulcer","enrollment":38},{"nctId":"NCT05925608","phase":"PHASE1, PHASE2","title":"Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioCardia, Inc.","startDate":"2023-08-23","conditions":"Heart Failure, Systolic","enrollment":39},{"nctId":"NCT05559801","phase":"PHASE1, PHASE2","title":"Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI)","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-02","conditions":"Osteogenesis Imperfecta, Osteogenesis Imperfecta Type III","enrollment":12},{"nctId":"NCT05727878","phase":"PHASE2","title":"Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED","status":"TERMINATED","sponsor":"Combangio, Inc","startDate":"2023-02-07","conditions":"Persistent Corneal Epithelial Defect","enrollment":103},{"nctId":"NCT04735185","phase":"NA","title":"Stem Cells vs. Steroids for Discogenic Back Pain","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2025-09-30","conditions":"Chronic Low Back Pain, Degenerative Disc Disease","enrollment":""},{"nctId":"NCT01071577","phase":"","title":"Collection of Bone Marrow From Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products","status":"TERMINATED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2010-03-17","conditions":"Bone Marrow Stromal Cells","enrollment":65},{"nctId":"NCT03477942","phase":"PHASE1","title":"Impact of Mesenchymal Stem Cells in Knee Osteoarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2018-10-01","conditions":"Musculoskeletal Pain, Knee Osteoarthritis, Cartilage Injury","enrollment":16},{"nctId":"NCT02685098","phase":"PHASE1","title":"A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation","status":"COMPLETED","sponsor":"Indiana University","startDate":"2017-01-23","conditions":"Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease","enrollment":81},{"nctId":"NCT07177677","phase":"PHASE1","title":"A Study of Mesenchymal Stem Cell in the Treatment of Autism Spectrum Disorder","status":"NOT_YET_RECRUITING","sponsor":"Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.","startDate":"2025-09-30","conditions":"Autism Spectrum Disorder","enrollment":42},{"nctId":"NCT07176143","phase":"NA","title":"hBMSC Uterine Artery Infusion for Severe IUA-Related Infertility","status":"NOT_YET_RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2025-09-30","conditions":"Intrauterine Adhesions","enrollment":60},{"nctId":"NCT05854641","phase":"PHASE4","title":"Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease","status":"RECRUITING","sponsor":"Cell Biopeutics Resources Sdn Bhd","startDate":"2024-01-01","conditions":"Critical Limb Ischemia, Peripheral Arterial Disease","enrollment":10},{"nctId":"NCT05854615","phase":"PHASE4","title":"Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease","status":"RECRUITING","sponsor":"Cell Biopeutics Resources Sdn Bhd","startDate":"2024-01-01","conditions":"Critical Limb Ischemia, Buerger's Disease","enrollment":3},{"nctId":"NCT07161128","phase":"NA","title":"Gait Pattern Analysis After Arthroscopic Treament of Osteochondral Defects of Talus","status":"ENROLLING_BY_INVITATION","sponsor":"Gazi University","startDate":"2024-06-01","conditions":"Osteochondral Defects of Talus, Gait Analysis, Microfracture Procedure","enrollment":60},{"nctId":"NCT07149896","phase":"PHASE3","title":"A Study of Collagen Scaffold for the Repair of Elbow Cartilage Injury","status":"NOT_YET_RECRUITING","sponsor":"Beijing Jishuitan Hospital","startDate":"2025-08","conditions":"Cartilage Defect, Elbow Injury","enrollment":90},{"nctId":"NCT07146087","phase":"EARLY_PHASE1","title":"Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis","status":"SUSPENDED","sponsor":"Biocells Medical","startDate":"2020-07-01","conditions":"Multiple Sclerosis","enrollment":20},{"nctId":"NCT04042844","phase":"PHASE2","title":"A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)","status":"RECRUITING","sponsor":"BioRestorative Therapies","startDate":"2022-06-30","conditions":"Lumbar Disc Disease","enrollment":99},{"nctId":"NCT03822858","phase":"","title":"Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis","status":"AVAILABLE","sponsor":"Tisch Multiple Sclerosis Research Center of New York","startDate":"","conditions":"Multiple Sclerosis","enrollment":""},{"nctId":"NCT07101562","phase":"NA","title":"Clinical Transformation of Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Avascular Necrosis of Femur Head","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Xinxiang Medical College","startDate":"2025-07-30","conditions":"Avascular Necrosis of Femur Head","enrollment":30},{"nctId":"NCT05925036","phase":"PHASE1","title":"Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-01-01","conditions":"Chronic Pancreatitis, Chronic Pain","enrollment":40},{"nctId":"NCT07094100","phase":"NA","title":"Tissue Engineered Cartilage to Repairing Articular Cartilage Defects","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Xinxiang Medical College","startDate":"2025-07-20","conditions":"Cartilage Injury, OA Knee","enrollment":30},{"nctId":"NCT06205342","phase":"EARLY_PHASE1","title":"Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2024-07-17","conditions":"Chronic Pancreatitis, Chronic Pain","enrollment":48},{"nctId":"NCT02484950","phase":"NA","title":"Mesenchymal Stem Cell Augmentation in Patients Undergoing Arthroscopic Rotator Cuff Repair","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2015-11-15","conditions":"Full Thickness Rotator Cuff Tear","enrollment":62},{"nctId":"NCT05027581","phase":"PHASE2","title":"Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)","status":"COMPLETED","sponsor":"Taiwan Bio Therapeutics Inc.","startDate":"2021-10-13","conditions":"Osteoarthritis, Knee","enrollment":72},{"nctId":"NCT04173650","phase":"PHASE1, PHASE2","title":"MSC EVs in Dystrophic Epidermolysis Bullosa","status":"RECRUITING","sponsor":"Aegle Therapeutics","startDate":"2024-08-13","conditions":"Dystrophic Epidermolysis Bullosa","enrollment":8},{"nctId":"NCT03522545","phase":"PHASE1","title":"Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-04-20","conditions":"Treatment-resistant Bipolar Depression","enrollment":30},{"nctId":"NCT03355365","phase":"PHASE2","title":"Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis","status":"COMPLETED","sponsor":"Tisch Multiple Sclerosis Research Center of New York","startDate":"2018-09-21","conditions":"Multiple Sclerosis","enrollment":54},{"nctId":"NCT06997939","phase":"PHASE1, PHASE2","title":"Autologous Bone Marrow Mesenchymal Stem Cell Therapy for Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Affiliated Hospital of Nantong University","startDate":"2025-06-01","conditions":"Ischemic Stroke","enrollment":12},{"nctId":"NCT05066334","phase":"PHASE2","title":"Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Campus Bio-Medico","startDate":"2021-03-22","conditions":"Intervertebral Disc Degeneration, Chronic Low-back Pain","enrollment":52},{"nctId":"NCT04759105","phase":"PHASE2","title":"Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Campus Bio-Medico","startDate":"2019-11-03","conditions":"Intervertebral Disc Degeneration, Chronic Low-back Pain","enrollment":48},{"nctId":"NCT06242379","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa","status":"RECRUITING","sponsor":"Mahidol University","startDate":"2024-05-23","conditions":"Retinitis Pigmentosa","enrollment":15},{"nctId":"NCT04447833","phase":"PHASE1","title":"Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Uppsala University","startDate":"2020-06-17","conditions":"ARDS, Human, COVID","enrollment":7},{"nctId":"NCT06896344","phase":"","title":"Role of Mesenchymal Stromal Cell Derived Extracellular Vesicles of Primary Myelofibrosis Patients on CD34+ Cells","status":"RECRUITING","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2024-01-11","conditions":"Primary Myelofibrosis","enrollment":10},{"nctId":"NCT02582489","phase":"NA","title":"Autologous Bone Marrow Aspirate Concentrate in Patients Undergoing Meniscectomy","status":"RECRUITING","sponsor":"Rush University Medical Center","startDate":"2017-12-22","conditions":"Osteoarthritis Post-meniscectomy","enrollment":100},{"nctId":"NCT05947175","phase":"NA","title":"Vertebral Bone Marrow Clot for Spinal Surgery","status":"RECRUITING","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2023-05-19","conditions":"Degenerative Spine Diseases","enrollment":96},{"nctId":"NCT06111846","phase":"PHASE2","title":"Study of Human Bone Marrow Mesenchymal Stem Cells in APAP","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.","startDate":"2023-12-25","conditions":"Autoimmune Pulmonary Alveolar Proteinosis","enrollment":10},{"nctId":"NCT06888973","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute of Blood and Marrow Transplant (NIBMT), Pakistan","startDate":"2025-02-01","conditions":"Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Systemic Sclerosis","enrollment":200},{"nctId":"NCT03011541","phase":"NA","title":"Stem Cell Ophthalmology Treatment Study II","status":"RECRUITING","sponsor":"MD Stem Cells","startDate":"2016-01","conditions":"Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa","enrollment":500},{"nctId":"NCT06858254","phase":"PHASE1, PHASE2","title":"Standard Optimization of Stem Cells in Parkinson's Disease and Atypical Parkinsonism","status":"NOT_YET_RECRUITING","sponsor":"Apeiron Research Center","startDate":"2025-04-01","conditions":"Atypical Parkinsonism, Parkinson Disease (PD)","enrollment":60},{"nctId":"NCT06822686","phase":"NA","title":"Autologous Stem Cells in the Management of Fistulating Perianal Crohn's Disease","status":"NOT_YET_RECRUITING","sponsor":"Oxford University Hospitals NHS Trust","startDate":"2025-03-01","conditions":"Fistula in Ano, Crohn Disease","enrollment":10},{"nctId":"NCT05836883","phase":"PHASE1, PHASE2","title":"Study of ExoFlo for the Treatment of Perianal Fistulas","status":"TERMINATED","sponsor":"Direct Biologics, LLC","startDate":"2023-08-28","conditions":"Perianal Fistula, Crohn's Disease","enrollment":5},{"nctId":"NCT05130983","phase":"PHASE1","title":"Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease","status":"TERMINATED","sponsor":"Direct Biologics, LLC","startDate":"2023-01-23","conditions":"Crohn Disease, Inflammatory Bowel Diseases","enrollment":3},{"nctId":"NCT05176366","phase":"PHASE1","title":"Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis","status":"TERMINATED","sponsor":"Direct Biologics, LLC","startDate":"2022-12-19","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases","enrollment":4},{"nctId":"NCT06798064","phase":"","title":"Expanded Access Using Allogeneic Bone-marrow Derived Human Mesenchymal Stem Cells (Allo-hMSC) for a Individual Parkinson's Disease Subject","status":"NO_LONGER_AVAILABLE","sponsor":"Mya Schiess","startDate":"","conditions":"Parkinson Disease","enrollment":""},{"nctId":"NCT01606215","phase":"PHASE1, PHASE2","title":"Stem Cells in Rapidly Evolving Active Multiple Sclerosis","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2013-01","conditions":"Multiple Sclerosis","enrollment":21},{"nctId":"NCT04745299","phase":"PHASE3","title":"Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients with ALS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Corestemchemon, Inc.","startDate":"2021-03-23","conditions":"Amyotrophic Lateral Sclerosis","enrollment":115},{"nctId":"NCT04522505","phase":"","title":"Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis","status":"COMPLETED","sponsor":"Corestemchemon, Inc.","startDate":"2017-11-29","conditions":"Lupus Nephritis","enrollment":6},{"nctId":"NCT06764329","phase":"PHASE1, PHASE2","title":"The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia.","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute of Blood and Marrow Transplant (NIBMT), Pakistan","startDate":"2024-12-25","conditions":"Androgenetic Alopecia, Androgenetic Alopecia (AGA)","enrollment":70},{"nctId":"NCT04410731","phase":"PHASE1","title":"Allogeneic BM-MSCs in Patients with Lumbar Facet Arthropathy","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2020-04-28","conditions":"Facet-Mediated Low Back Pain","enrollment":10},{"nctId":"NCT06740149","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of BMSCs (CG-BM1) for ACLF Patients","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2023-03-01","conditions":"Acute-On-Chronic Liver Failure","enrollment":90},{"nctId":"NCT03325504","phase":"PHASE3","title":"A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union","status":"COMPLETED","sponsor":"Universidad Autonoma de Madrid","startDate":"2017-09-05","conditions":"Non Union Fracture","enrollment":46},{"nctId":"NCT06361797","phase":"NA","title":"Varying Bone Marrow-Derived Mesenchymal Stem Cells Concentrations' Impact on Rotator Cuff Repair Outcomes","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2025-02","conditions":"Rotator Cuff Tears","enrollment":""},{"nctId":"NCT05086939","phase":"PHASE3","title":"Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León","startDate":"2021-05-26","conditions":"Knee Osteoarthritis","enrollment":124},{"nctId":"NCT05116761","phase":"PHASE1, PHASE2","title":"ExoFlo™ Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 Syndrome","status":"WITHDRAWN","sponsor":"Direct Biologics, LLC","startDate":"2024-11","conditions":"Covid19, Postviral Syndrome, Dyspnea","enrollment":""},{"nctId":"NCT04657458","phase":"","title":"Expanded Access for Use of bmMSC-Derived Extracellular Vesicles in Patients With COVID-19 Associated ARDS","status":"NO_LONGER_AVAILABLE","sponsor":"Direct Biologics, LLC","startDate":"","conditions":"Covid19, ARDS, Hypoxia","enrollment":""},{"nctId":"NCT05078385","phase":"PHASE1","title":"Safety of Extracellular Vesicles for Burn Wounds","status":"COMPLETED","sponsor":"Aegle Therapeutics","startDate":"2023-08-10","conditions":"Burns","enrollment":1},{"nctId":"NCT06676423","phase":"PHASE1","title":"Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With ALS","status":"COMPLETED","sponsor":"Corestemchemon, Inc.","startDate":"2022-11-09","conditions":"Amyotrophic Lateral Sclerosis","enrollment":8},{"nctId":"NCT03265444","phase":"PHASE1","title":"Safety and Tolerability of CS10BR05 Inj. in Subjects with Multiple System Atrophy","status":"COMPLETED","sponsor":"Corestemchemon, Inc.","startDate":"2018-04-13","conditions":"Multiple System Atrophy","enrollment":9},{"nctId":"NCT02582775","phase":"PHASE2","title":"MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2016-03","conditions":"Epidermolysis Bullosa","enrollment":17},{"nctId":"NCT04397796","phase":"PHASE1","title":"Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation","status":"TERMINATED","sponsor":"ImmunityBio, Inc.","startDate":"2020-08-03","conditions":"COVID","enrollment":4},{"nctId":"NCT05362786","phase":"PHASE1","title":"Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease","status":"COMPLETED","sponsor":"LaTonya J. Hickson","startDate":"2022-07-01","conditions":"Chronic Kidney Diseases","enrollment":14},{"nctId":"NCT05215288","phase":"","title":"Expanded Access for Use of ExoFlo in Abdominal Solid Organ Transplant Patients","status":"NO_LONGER_AVAILABLE","sponsor":"Direct Biologics, LLC","startDate":"","conditions":"Solid Organ Transplant Rejection, Organ Rejection Transplants, Organ Rejection","enrollment":""},{"nctId":"NCT05127122","phase":"PHASE1, PHASE2","title":"Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS","status":"WITHDRAWN","sponsor":"Direct Biologics, LLC","startDate":"2024-12","conditions":"ARDS, Human","enrollment":""},{"nctId":"NCT04506073","phase":"PHASE2","title":"Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson's Disease","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-11-09","conditions":"Parkinson's Disease","enrollment":45},{"nctId":"NCT06469411","phase":"PHASE3","title":"Effect of PMSCs and Their Secretome for the Treatment of GvHD","status":"COMPLETED","sponsor":"Tabriz University of Medical Sciences","startDate":"2023-01-01","conditions":"GVHD","enrollment":60},{"nctId":"NCT03343782","phase":"PHASE1, PHASE2","title":"Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2017-11-01","conditions":"Type 2 Diabetes Mellitus","enrollment":30},{"nctId":"NCT03356821","phase":"PHASE1, PHASE2","title":"Perinatal Arterial Stroke Treated With Stromal Cells Intranasally","status":"COMPLETED","sponsor":"UMC Utrecht","startDate":"2020-02-11","conditions":"Perinatal Arterial Ischemic Stroke, Neonatal Stroke","enrollment":10},{"nctId":"NCT02525432","phase":"PHASE2","title":"Autologous Stem Cell Study for Adult TBI (Phase 2b)","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2016-11-21","conditions":"Brain Injuries, Traumatic, Brain Injuries, Acute, TBI (Traumatic Brain Injury)","enrollment":37},{"nctId":"NCT06400862","phase":"PHASE1","title":"Treating Patients With Traumatic Chondral Lesions With Autologous Bone Marrow Cells Derived Engineered Tissues - Engineered Osteochondral Tissue","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2024-02-26","conditions":"Traumatic Cartilage Injury","enrollment":9},{"nctId":"NCT01860417","phase":"PHASE1, PHASE2","title":"Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)","status":"COMPLETED","sponsor":"Red de Terapia Celular","startDate":"2013-06-21","conditions":"Degenerative Disc Disease, Intervertebral Disc Disease, Low Back Pain","enrollment":24},{"nctId":"NCT06087848","phase":"PHASE1, PHASE2","title":"A Study to Evaluate Mesenchymal Stem Cell Product StromaForte's Effect on Cardiovascular Events","status":"RECRUITING","sponsor":"Cellcolabs Clinical LTD.","startDate":"2023-10-07","conditions":"Cardiovascular Diseases","enrollment":100},{"nctId":"NCT01033552","phase":"PHASE1, PHASE2","title":"Biochemical Correction of Severe EB by Allo HSCT and \"Off-the-shelf\" MSCs","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2010-01","conditions":"Epidermolysis Bullosa","enrollment":32},{"nctId":"NCT05042206","phase":"PHASE1","title":"Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2021-11-24","conditions":"Chronic Kidney Disease Stage 3B, Chronic Kidney Disease stage4","enrollment":10},{"nctId":"NCT04689152","phase":"PHASE3","title":"Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis","status":"RECRUITING","sponsor":"Pharmicell Co., Ltd.","startDate":"2021-03-02","conditions":"Alcoholic Cirrhosis","enrollment":200},{"nctId":"NCT03280056","phase":"PHASE3","title":"Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients","status":"COMPLETED","sponsor":"Brainstorm-Cell Therapeutics","startDate":"2017-08-28","conditions":"Amyotrophic Lateral Sclerosis (ALS)","enrollment":196}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9395,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Chondrochymal®"],"phase":"phase_3","status":"active","brandName":"Bone marrow mesenchymal stem cells","genericName":"Bone marrow mesenchymal stem cells","companyName":"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia","companyId":"federal-research-clinical-center-of-federal-medical-biological-agency-russia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bone marrow mesenchymal stem cells are being studied in clinical trials for conditions such as multiple sclerosis, perianal Crohn disease, and perianal fistula. The exact mechanism of action of bone marrow mesenchymal stem cells is currently unknown.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}